Nikon is trying to reignite growth by pushing harder into pro video through its RED deal and by building a new healthcare engine around cell therapy manufacturing. But a slower comeback in chip-related equipment, currency swings, and a tougher healthcare backdrop could still weigh on results.Read more

JP¥1.71k

26.9% overvalued

AnalystConsensusTarget's

Fair Value

Profit Margin

3.89%

Future PE

22.91x

Price in 2029

JP¥2.08k

Trending Discussion

No trending discussion available.

Snowflake Analysis

Fair value with moderate growth potential.

1 Risk

2 Rewards

View Full Analysis

Nikon Corporation Key Details

Last Reported Earnings

Mar 31, 2026

Next Reporting Earnings

Aug 06, 2026

: -261.33
: 40.94%
: -12.71%
: 37.4%

View Full Analysis

About 7731

Founded: 1917
Employees: 19928
CEO: Yasuhiro Ohmura
WebsiteView website: www.nikon.com

Nikon Corporation manufactures and sells optical instruments in Japan, North America, Europe, China, Thailand, and internationally. It operates through Imaging Business, Precision Equipment Business, Healthcare Business, Components Business, and Digital Manufacturing Business segments. The Imaging Business segment provides interchangeable-lens and integrated-lens digital cameras, digital cinema cameras, and others. The Precision Equipment Business segment offers FPD exposure equipment. The Healthcare Business segment provides products and services for the life science solutions field, such as biological microscopes and cell culture observation equipment. The Components Business segment offers industrial microscopes, measuring instruments, X-ray/CT inspection systems, optical components, optical parts and engineering equipment; and CODA, custom products, such as EUV-related components and space-related products. The Digital Manufacturing Business provides products and services of metal 3D printers. Nikon Corporation was incorporated in 1917 and is headquartered in Shinagawa, Japan.